Literature DB >> 20847745

Cellular sources and immune functions of interleukin-9.

Randolph J Noelle1, Elizabeth C Nowak.   

Abstract

Interleukin-9 (IL-9) has attracted renewed interest owing to the identification of its expression by multiple T helper (T(H)) cell subsets, including T(H)2 cells, T(H)9 cells, T(H)17 cells and regulatory T (T(Reg)) cells. Here, we provide a broad overview of the conditions that are required for cells to produce IL-9 and describe the cellular targets and nature of the immune responses that are induced by IL-9.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20847745      PMCID： PMC3828627          DOI： 10.1038/nri2848

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN： 1474-1733            Impact factor:   53.106


  48 in total

1.  Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE.

Authors:  Yawei Liu; Ingrid Teige; Bryndis Birnir; Shohreh Issazadeh-Navikas
Journal:  Nat Med       Date:  2006-04-23       Impact factor: 53.440

2.  The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4.

Authors:  Anne Brüstle; Sylvia Heink; Magdalena Huber; Christine Rosenplänter; Christine Stadelmann; Philipp Yu; Enrico Arpaia; Tak W Mak; Thomas Kamradt; Michael Lohoff
Journal:  Nat Immunol       Date:  2007-08-05       Impact factor: 25.606

3.  Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients.

Authors:  Toshihiro Nagato; Hiroya Kobayashi; Kan Kishibe; Miki Takahara; Takeshi Ogino; Hideyuki Ishii; Kensuke Oikawa; Naoko Aoki; Keisuke Sato; Shoji Kimura; Norio Shimizu; Masatoshi Tateno; Yasuaki Harabuchi
Journal:  Clin Cancer Res       Date:  2005-12-01       Impact factor: 12.531

4.  IL-9 is associated with an impaired Th1 immune response in patients with tuberculosis.

Authors:  Bo Wu; Chunhong Huang; Midori Kato-Maeda; Philip C Hopewell; Charles L Daley; Alan M Krensky; Carol Clayberger
Journal:  Clin Immunol       Date:  2007-11-26       Impact factor: 3.969

5.  IL-9 promotes IL-13-dependent paneth cell hyperplasia and up-regulation of innate immunity mediators in intestinal mucosa.

Authors:  Valérie Steenwinckel; Jamila Louahed; Muriel M Lemaire; Caroline Sommereyns; Guy Warnier; Andrew McKenzie; Frank Brombacher; Jacques Van Snick; Jean-Christophe Renauld
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

6.  Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset.

Authors:  Marc Veldhoen; Catherine Uyttenhove; Jacques van Snick; Helena Helmby; Astrid Westendorf; Jan Buer; Bruno Martin; Christoph Wilhelm; Brigitta Stockinger
Journal:  Nat Immunol       Date:  2008-10-19       Impact factor: 25.606

7.  Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4+CD44hi Cells.

Authors:  Jonathan A Hill; Jason A Hall; Cheng-Ming Sun; Qi Cai; Norbert Ghyselinck; Pierre Chambon; Yasmine Belkaid; Diane Mathis; Christophe Benoist
Journal:  Immunity       Date:  2008-11-14       Impact factor: 31.745

8.  IL-13 mediates in vivo IL-9 activities on lung epithelial cells but not on hematopoietic cells.

Authors:  Valérie Steenwinckel; Jamila Louahed; Ciriana Orabona; François Huaux; Guy Warnier; Andrew McKenzie; Dominique Lison; Roy Levitt; Jean-Christophe Renauld
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

9.  IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells.

Authors:  Valérie Dardalhon; Amit Awasthi; Hyoung Kwon; George Galileos; Wenda Gao; Raymond A Sobel; Meike Mitsdoerffer; Terry B Strom; Wassim Elyaman; I-Cheng Ho; Samia Khoury; Mohamed Oukka; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2008-11-09       Impact factor: 25.606

10.  IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity.

Authors:  Elizabeth E Forbes; Katherine Groschwitz; J Pablo Abonia; Eric B Brandt; Elizabeth Cohen; Carine Blanchard; Richard Ahrens; Luqman Seidu; Andrew McKenzie; Richard Strait; Fred D Finkelman; Paul S Foster; Klaus I Matthaei; Marc E Rothenberg; Simon P Hogan
Journal:  J Exp Med       Date:  2008-03-31       Impact factor: 14.307
View more
  107 in total

Review 1.  Dietary agents in cancer prevention: an immunological perspective.

Authors:  Ya Ying Zheng; Bharathi Viswanathan; Pravin Kesarwani; Shikhar Mehrotra
Journal:  Photochem Photobiol       Date:  2012-03-30       Impact factor: 3.421

2.  [Th9 cells. Functionally important or just an epiphenomenon?].

Authors:  A Ramming; H Schulze-Koops; A Skapenko
Journal:  Z Rheumatol       Date:  2012-07       Impact factor: 1.372

Review 3.  IL-9 and Th9 cells: progress and challenges.

Authors:  Picheng Zhao; Xiang Xiao; Rafik M Ghobrial; Xian C Li
Journal:  Int Immunol       Date:  2013-09-11       Impact factor: 4.823

Review 4.  IL-9 and Th9 cells in health and diseases-From tolerance to immunopathology.

Authors:  Junhui Li; Shuqiu Chen; Xiang Xiao; Yong Zhao; Wenjun Ding; Xian C Li
Journal:  Cytokine Growth Factor Rev       Date:  2017-07-17       Impact factor: 7.638

5.  Phenotypes of Th lineages generated by the commonly used activation with anti-CD3/CD28 antibodies differ from those generated by the physiological activation with the specific antigen.

Authors:  Cuiyan Tan; Lai Wei; Barbara P Vistica; Guangpu Shi; Eric F Wawrousek; Igal Gery
Journal:  Cell Mol Immunol       Date:  2014-03-03       Impact factor: 11.530

6.  Opposing actions of IL-2 and IL-21 on Th9 differentiation correlate with their differential regulation of BCL6 expression.

Authors:  Wei Liao; Rosanne Spolski; Peng Li; Ning Du; Erin E West; Min Ren; Suman Mitra; Warren J Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-18       Impact factor: 11.205

7.  Genome-wide expression profiles identify potential targets for gene-environment interactions in asthma severity.

Authors:  Joanne E Sordillo; Roxanne Kelly; Supinda Bunyavanich; Michael McGeachie; Weiliang Qiu; Damien C Croteau-Chonka; Manuel Soto-Quiros; Lydiana Avila; Juan C Celedón; John M Brehm; Scott T Weiss; Diane R Gold; Augusto A Litonjua
Journal:  J Allergy Clin Immunol       Date:  2015-04-24       Impact factor: 10.793

8.  Role of high expression of IL-9 in prognosis of CLL.

Authors:  Na Chen; Xiao Lv; Peipei Li; Kang Lu; Xin Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

9.  Th9 cells promote antitumor immune responses in vivo.

Authors:  Yong Lu; Sungyoul Hong; Haiyan Li; Jungsun Park; Bangxing Hong; Lijuan Wang; Yuhuan Zheng; Zhiqiang Liu; Jingda Xu; Jin He; Jing Yang; Jianfei Qian; Qing Yi
Journal:  J Clin Invest       Date:  2012-10-15       Impact factor: 14.808

10.  Comparison of low-abundance biomarker levels in capillary-collected nonstimulated tears and washout tears of aqueous-deficient and normal patients.

Authors:  Nicole Guyette; Larezia Williams; My-Tho Tran; Tammy Than; John Bradley; Lucy Kehinde; Clara Edwards; Mark Beasley; Roderick Fullard
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-05-01       Impact factor: 4.799
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.